Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.1 USD | +7.73% | +15.27% | +56.15% |
May. 14 | Stephens Initiates Nurix Therapeutics With Overweight Rating, $20 Price Target | MT |
Apr. 12 | Sector Update: Health Care Stocks Steady Pre-Bell Friday | MT |
- Stock Market
- Equities
- NRIX Stock
- News Nurix Therapeutics, Inc.
- MarketScreener Editorial Features